To provide direct financial assistance to eligible
metropolitan areas (EMAs) that have been the most severely affected by the
Human Immunodeficiency Virus (HIV) epidemic to develop, organize and operate
programs that provide an effective, appropriate and cost efficient continuum
of health care and support services for the individuals and families with HIV
disease.
TYPES OF ASSISTANCE:
Project Grants. Place Cursor Here for Definition
USES AND USE RESTRICTIONS:
Funds received under a grant are to be used to provide
direct financial assistance for the purpose of delivering or enhancing
HIV-related outpatient and ambulatory health and support services, including
case management, substance abuse treatment and mental health treatment, and
comprehensive treatment services, including treatment education and
prophylactic treatment for opportunistic infections, for individuals and
families with HIV disease; and inpatient case management services that prevent
unnecessary hospitalization or that expedite discharge, as medically
appropriate, from inpatient facilities. A percentage of the grant, determined
by the percentage of women, infants, and children in the area with Acquired
Immune Deficiency Syndrome, will be used to provide health and support
services to infants, children, and women with HIV disease, including treatment
measures to prevent the perinatal transmission of HIV. No more than 10 percent
of amounts received under a grant may be used to reduce severe personnel
shortages in institutional, inpatient settings such as hospitals and nursing
homes. Funds may not be used to supplant or replace the resources of such
institutional providers that are already devoted to the support of personnel
providing HIV-related services. Funds may not be used to purchase or improve
land, or to purchase, construct or make permanent improvement to any building
except for minor remodeling. Funds may not be used to make payments to
recipients of services. No more than five percent of funds awarded under a
grant may be used for administration, accounting, reporting, and program
oversight functions.
ELIGIBILITY REQUIREMENTS:
Applicant Eligibility: All
previous eligible metropolitan areas (EMA) and all metropolitan areas with a
population of 500,000 or more individuals for which the Centers for Disease
Control and Prevention has reported a cumulative total of more than 2,000
cases of acquired immune deficiency syndrome for the most recent period of 5
calendar years that data are available. Previous EMAs include: Atlanta,
Georgia; Baltimore, Maryland; Boston, Massachusetts; Chicago, Illinois;
Dallas, Texas; Ft. Lauderdale, Florida; Houston, Texas; Los Angeles,
California; Miami, Florida; New York, New York; Newark, New Jersey; Oakland,
California; Philadelphia, Pennsylvania; San Diego, California; San Francisco,
California; San Juan, Puerto Rico; Washington, DC; Orange County, California;
Nassau/Suffolk Counties, New York; Detroit, Michigan; Seattle, Washington; New
Orleans, Louisiana; Tampa, Florida. Petersburg, Florida; Ponce, Puerto Rico;
Paterson, New Jersey; Denver, Colorado; Kansas City, Missouri; New Haven,
Connecticut; Orange County, Florida; Phoenix, Arizona; San Bernardino,
California; St. Louis, Missouri; West Palm Beach, Florida; Jacksonville,
Florida; Austin, Texas; San Antonio, Texas; Portland, Oregon; Jersey City, New
Jersey, Ponce, Puerto Rico; Caguas, Puerto Rico; Dutchess County, New York;
Vineland, New Jersey; Santa Rosa, California; Cleveland, Ohio; Fort Worth,
Texas; Hartford, Connecticut; Middlesex, New Jersey; Minneapolis, Minnesota;
Sacramento, California; San Jose, California; Las Vegas, Nevada; and Norfolk,
Virginia.
Beneficiary Eligibility:
Individuals and families with HIV disease will benefit.
Credentials/Documentation:
OMB Circular No. A-87, Cost Principles for State and Local Governments; OMB
Circular No. A-102, Uniform Administrative Requirements for Grants and
Cooperative Agreements to State and Local Governments; and Public Health
Service Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000 (Rev.)
April 1, 1994.
Pre-application Coordination:
There is no pre-application submittal required. This program is eligible for
coverage under E.O. 12372, "Intergovernmental Review of Federal
Programs." An applicant should consult the office or official designated
as the single point of contact in his or her State for more information on the
process the State requires to be followed in applying for assistance, if the
State has selected the program for review.
Application Procedure:
Applicants are to use the standard PHS Form 5161 for submitting applications.
Applications may be obtained by writing to the Grants Management Branch, c/o
HRSA Grants Application Center, 901 Russell Avenue, Suite 450, Gaithersburg,
MD 20879 or by calling 1-877-477-2123.
Award Procedure:
Applications will undergo an internal review process for funds awarded under
Section 2603(a)(3). For funds awarded under Section 2603(b), applications will
be reviewed by an Objective Grant Review Committee composed of representatives
from various Department of Health and Human Services agencies, as well as
outside reviewers that are experts in the field of HIV services planning and
service delivery. Grants will be awarded to eligible metropolitan areas.
Deadlines: Contact the
Headquarters Office listed below for deadline dates.
Range of Approval/Disapproval Time:
About 60 days.
Appeals: None.
Renewals: None.
ASSISTANCE CONSIDERATIONS:
Formula and Matching Requirements:
None.
Length and Time Phasing of Assistance:
Grants are awarded for a 12-month budget period.
POST ASSISTANCE REQUIREMENTS:
Reports: Annual progress and
annual financial reports are required. Annual reports are to be submitted
within 90 days after the end of each budget period. The final performance
report and final financial status reports are due 90 days from the end of the
project period. Reports documenting services and costs will also be required.
Audits: In accordance with
the provisions of OMB Circular No. A-133 (Revised, June 24, 1997),
"Audits of States, Local Governments, and Nonprofit Organizations,"
nonfederal entities that expend financial assistance of $300,000 or more in
Federal awards will have a single or a program-specific audit conducted for
that year. Nonfederal entities that expend less than $300,000 a year in
Federal awards are exempt from Federal audit requirements for that year,
except as noted in Circular No. A-133. In addition, grants and cooperative
agreements are subject to inspection and audits by DHHS and other Federal
government officials.
Records: All financial and
programmatic records, supporting documents, statistical records, and other
records of grantees and sub-grantees must be retained for a period of 3 years.
For grants that are renewed at annual intervals, the retention period for the
records of each funding period starts on the day the grantee or sub-grantee
submits to the awarding agency its single or last expenditure report for that
period. The awarding agency and the Comptroller General of the United States,
or any of their authorized representatives, shall have the right of access to
any pertinent books, documents, papers, or other records of grantees and
sub-grantees which are pertinent to the grant, in order to make audits,
examinations, excepts, and transcripts.
FINANCIAL INFORMATION:
Account Identification:
75-0350-0-1-550.
Obligations: (Grants) FY 01
$582,727,700; FY 02 est $597,256,000; and FY 03 est $597,256,000.
Range and Average of Financial Assistance:
From $910,779 to $117,739,488. Average: $11,710,901.
In fiscal year 2001, 51 continuation awards were made.
It is estimated that 51 competing continuation awards will be made in fiscal
year 2002. It is anticipated that 51 non-competing continuation awards will be
made in fiscal year 2003.
Headquarters Office:
Program Contact: Douglas Morgan, Director, Division of Service Systems,
HIV/AIDS Bureau, Health Resources and Services Administration, 5600 Fishers
Lane, Room 7A-55, Rockville, MD 20857. Telephone: (301) 443-6745. Grants
Management Contact: Ms. Helen Harpold, Grants Management Specialist, Grants
Management Branch, Office of Program Support, HIV/AIDS Bureau, Health
Resources and Services Administration, 5600 Fishers Lane, Room 7-89,
Rockville, MD 20857. Telephone: (301) 443-2280. Use the same numbers for FTS.
Web Site Address: http://www.hrsa.gov
EXAMPLES OF FUNDED PROJECTS:
Programs were funded to deliver or enhance HIV-related
outpatient and ambulatory health and support services, including case
management and comprehensive treatment services for individual and families
with HIV disease and inpatient case management services.
CRITERIA FOR SELECTING PROPOSALS:
Applications must meet seven criteria set forth in the
enacting legislation: (1) Contain a report concerning the dissemination of
emergency relief funds and the plan for utilization of such funds; (2)
demonstrate the severe need in such area for supplemental financial assistance
to combat the HIV epidemic; (3) demonstrate the existing commitment of local
resources of the area, both financial and in-kind, to combat the HIV epidemic;
(4) demonstrate the ability of the area to utilize such supplemental financial
resources in a manner that is immediately responsive and cost-effective; (5)
demonstrate that resources will be allocated in accordance with the local
demographic incidence of AIDS including appropriate allocations for services
for infants, children, women, and families with HIV disease; (6) demonstrate
the inclusiveness of the planning council membership, with particular emphasis
on affected communities and individuals with HIV disease; and (7) demonstrate
the manner in which proposed services are consistent with the local needs
assessment and the statewide coordinated statement of need.
